Semaglutide is linked to serious gastrointestinal issues in 1% of patients
Semaglutide is the active ingredient in the brand names Ozempic, Wegovy, and Rybelsus. These drugs warn of gastrointestinal side effects like diarrhea, nausea, and indigestion. These side effects are common and affect around 50% of users.
However, in the JAMA Network, a monthly medical journal published by the American Medical Association, a study concluded that the use of semaglutide heightened the risks of developing gastroparesis and bowel obstructions. Though rare, these severe side effects affect around 1% of semaglutide users. These side effects are not only devastating, but can sometimes be incurable as well.
Wegovy’s label already lists bowel obstruction as a potential side effect, but it still does not include gastroparesis, despite growing evidence that semaglutide can cause this chronic and painful condition.
We provide legal assistance for those affected by semaglutide
If you or a loved one is experiencing a serious side effect from the use of Wegovy, contact our firm as soon as possible. While this may be an emotionally draining situation, we'll do our best to stop it from being financially draining, too. With our expertise, you can recover financial compensation from Novo Nordisk to offset the costs of a devastating diagnosis.
Because we know that this is a difficult time for you, your involvement in the claim process will be minimal. All we need from you are your medical records with a proper diagnosis, proof of you having taken the drug, and any other documents that may strengthen your claim. With these documents, our experienced lawyers can assess whether or not you are eligible to file a claim against the manufacturer.